Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.5719
+0.0230 (4.19%)
At close: Dec 24, 2025, 1:00 PM EST
0.5688
-0.0031 (-0.54%)
After-hours: Dec 24, 2025, 4:59 PM EST

Plus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
7978111610
Upgrade
Market Cap Growth
858.48%-14.33%-25.69%-33.96%67.05%6.69%
Upgrade
Enterprise Value
6851-429
Upgrade
Last Close Price
0.571.151.754.7515.7530.30
Upgrade
PS Ratio
4.931.161.6147.55-31.86
Upgrade
PB Ratio
14.89-0.76-5.871.651.493.19
Upgrade
P/TBV Ratio
18.24--1.781.553.75
Upgrade
EV/Sales Ratio
13.010.930.30--29.48
Upgrade
Debt / Equity Ratio
1.27-0.38-3.100.880.652.31
Upgrade
Asset Turnover
0.410.650.280.01-0.02
Upgrade
Quick Ratio
1.220.270.801.533.140.98
Upgrade
Current Ratio
1.290.340.921.843.361.07
Upgrade
Return on Equity (ROE)
---522.50%-234.65%-193.25%-393.27%
Upgrade
Return on Assets (ROA)
-65.58%-101.93%-47.23%-53.74%-44.65%-31.14%
Upgrade
Return on Capital (ROIC)
-173.38%--111.58%-82.36%-54.64%-47.49%
Upgrade
Return on Capital Employed (ROCE)
-266.20%164.80%-2015.30%-164.10%-75.60%-246.90%
Upgrade
Earnings Yield
-26.18%-191.39%-168.24%-190.35%-83.08%-85.36%
Upgrade
FCF Yield
-20.07%-157.80%-164.38%-126.56%-64.63%-88.32%
Upgrade
Buyback Yield / Dilution
-682.06%-145.18%-79.45%-117.18%-173.03%-219.93%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q